[Federal Register Volume 78, Number 101 (Friday, May 24, 2013)]
[Notices]
[Pages 31554-31555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0612]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an email to [email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Well-Integrated Screening and Evaluation for Women Across the
Nation (WISEWOMAN) Reporting System (OMB 0920-0612, exp. 1/31/
2014)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Cardiovascular disease (CVD), which includes heart disease,
myocardial infarction, and stroke, is the leading cause of death for
women in the United States, and is largely preventable. The WISEWOMAN
program (Well-Integrated Screening and Evaluation for Women Across the
Nation), administered by the Centers for Disease Control and Prevention
(CDC), was established to examine ways to improve the delivery of
services for women who have limited access to health care and elevated
risk factors for CVD. The program focuses on reducing CVD risk factors
and provides screening services for select risk factors such as
elevated blood cholesterol, hypertension and abnormal blood glucose
levels. The program also provides women with referrals to lifestyle
programs and medical care. The WISEWOMAN program currently provides
services to approximately 45,000 women who are jointly enrolled in the
National Breast and Cervical Cancer Early Detection Program (NBCCEDP),
also administered by CDC. The current cooperative agreements for
WISEWOMAN awardees end June 30, 2013 and final submissions to CDC are
due no later than October 31, 2013. CDC obtained OMB approval to
collect information from these awardees through the ``WISEWOMAN
Reporting System,'' OMB No. 0920-0612, exp. 1/31/2014. The information
submitted to CDC includes semi-annual progress reports and minimum data
elements (MDE) that are also submitted twice per year.
The WISEWOMAN program will continue under a new set of four-year
cooperative agreements that begin July 1, 2013 and end June 30, 2017.
The new funding period will reflect an increased emphasis on efficient
oversight of program awardees and documenting program outcomes. As a
result, the WISEWOMAN information collection will be revised to support
updated program goals. Changes to be implemented in the new cooperative
agreement funding cycle include a reduction in the frequency of
progress report submission--from twice per year to once per year--and
changes to the content of the MDE submissions. The first reports based
on the revised reporting requirements will be submitted to CDC in April
2014.
The hardcopy progress report provides a narrative summary of each
awardee's objectives and the activities undertaken to meet program
goals, including public education and outreach. The estimated burden
per response is 8 hours. In the new cooperative agreement cycle, the
frequency of response will decrease from twice per year to once per
year, resulting in a net decrease in respondent
[[Page 31555]]
burden for progress reporting. In the future, CDC may transition from a
hardcopy report to MIS-based progress reporting.
The MDE information submitted to CDC includes baseline and follow-
up data (12 months post enrollment) for all women served through the
WISEWOMAN program. The MDE describe risk factors for the women served
in each program and the number and type of lifestyle program sessions
they attend. The information allows CDC to assess the effectiveness of
the WISEWOMAN program in reducing the burden of cardiovascular disease
risk factors among women who utilize program services. MDE information
may also be utilized in assessments of WISEWOMAN program impact and
cost-effectiveness. MDE information has previously been submitted to
CDC in two electronic transmissions: the burden for Screening and
Assessment MDE was estimated at 16 hours per response and the burden
for Lifestyle Intervention MDE was estimated at 8 hours per response.
Under the new WISEWOMAN cooperative agreements, the MDE will be
submitted as a single electronic file with a combined estimated burden
per response of 24 hours. The total number of MDE variables will
increase from 66 to 87. The number of variables relating to Lifestyle
Interventions will decrease and the number of variables relating to
Screening and Assessment will increase.
CDC will continue to use the information collected from WISEWOMAN
awardees to support continuous program monitoring and improvement
activities, evaluation, and assessment of program outcomes. The overall
program evaluation is designed to demonstrate how WISEWOMAN can obtain
more complete health data on vulnerable populations, promote public
education about disease incidence, cardiovascular disease risk-factors,
health promotion, to improve the availability of screening and
diagnostic services for under-served women, ensure the quality of
services provided to under-served women, and develop strategies for
improved interventions.
The estimated number of WISEWOMAN awardees is 21 but may be
adjusted when new cooperative agreements are issued. Participation in
this information collection is required as a condition of cooperative
agreement funding. There are no costs to respondents other than their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hrs)
respondent hrs)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Grantees Screening and 21 2 24 1,008
Assessment and
Lifestyle
Program MDEs.
Annual Progress 21 1 8 168
Report.
-------------------------------
Total..................... ................ .............. .............. .............. 1,176
----------------------------------------------------------------------------------------------------------------
Ron A. Otten,
Director, Office of Scientific Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013-12406 Filed 5-23-13; 8:45 am]
BILLING CODE 4163-18-P